Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by The University of Texas Health Science Center at San Antonio
Sponsor:
Information provided by (Responsible Party):
Ahmad Wehbe, The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier:
NCT01588431
First received: February 29, 2012
Last updated: February 24, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2022
  Estimated Primary Completion Date: December 2021 (Final data collection date for primary outcome measure)